Related Experiment Videos
The lupus anticoagulant and pregnancy
1Department of Family Medicine, Marshfield Clinic-Mercer Center, Wis.
The Journal of the American Osteopathic Association
|March 1, 1993
Summary
Lupus anticoagulant (LA) is a known condition, but its obstetric complications are rare. This review covers LA management in pregnancy, highlighting a case where prednisone and aspirin therapy led to a successful pregnancy after a prior spontaneous abortion.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Immunology
Background:
- Lupus anticoagulant (LA) is an antibody associated with an increased risk of thrombosis and pregnancy complications.
- While LA has been recognized for decades, its specific impact and management in obstetric cases remain less frequently reported.
- Understanding the interplay between LA and pregnancy outcomes is crucial for effective patient care.
Observation:
- A review of existing literature on lupus anticoagulant in pregnancy.
- A case report detailing a patient experiencing spontaneous abortion.
- The same patient's subsequent pregnancy managed with specific therapeutic interventions.
Findings:
- The literature review addresses current recommendations for managing lupus anticoagulant during pregnancy.
- The reported case illustrates a successful pregnancy outcome following a spontaneous abortion.
- Therapeutic intervention with prednisone and aspirin was associated with the successful second pregnancy.
Implications:
- This case underscores the importance of considering lupus anticoagulant in recurrent pregnancy loss.
- It highlights the potential efficacy of prednisone and aspirin therapy in managing LA-associated obstetric complications.
- Further research into optimal therapeutic strategies for lupus anticoagulant in pregnancy is warranted.